Automated Breast Ultrasound Systems (ABUS) Market to grow at a CAGR of 14.8% during 2024-2028
The Automated Breast Ultrasound Systems (ABUS) Market is expected to grow at a CAGR of 14.8% during 2023 and 2028. During this period, the market is also expected to show a growth of USD 666.5 million. In the dynamic landscape of the Automated Breast Ultrasound Systems (ABUS) market, companies are relentlessly innovating to enhance breast imaging technology. To actualize these advancements, securing adequate funding is paramount. QT Imaging Inc., a privately held corporation specializing in research, development, and commercialization, raised capital to bring their groundbreaking automated breast imaging system to fruition. Their QTscan technology, which generates high-resolution transmission ultrasound images without radiation, compression, or injections, received FDA 510(K) clearance in February 2019. This cutting-edge solution represents a significant stride in the early detection and diagnosis of breast cancer.
Get more information on Automated Breast Ultrasound Systems (ABUS) Market by requesting a sample report
Technavio analysts predict that the Diagnostic centers subsegment will lead the End-user segment during 2024 and 2028 The Automated Breast Ultrasound Systems (ABUS) market is experiencing significant growth due to its ability to complement traditional mammography and provide supplemental imaging for denser breasts. ABUS utilizes advanced imaging technologies to enhance diagnostic accuracy, reducing false positives and negative results. This technology is increasingly being adopted by healthcare providers to improve patient care and outcomes, driving market expansion.
Here are the various ways based on which the market is segmented:
There are several factors that are causing the market to flourish increasing demand for breast imaging products owing to the growing prevalence of breast cancer cases
Learn which are the obstacles that the market is experiencing in the way of its growth by accessing the free PDF report
Automated Breast Ultrasound Systems (ABUS) have emerged as a valuable Screening Tool in the field of Cancer Detection and Preventative Care. These systems use high-frequency sound waves to penetrate through Fatty Tissues and produce detailed 3D images of the breast, making it an essential supplement to Mammography, especially for women with Dense Breast Tissue. ABUS utilizes a Transducer that moves over the breast, sending and receiving sound waves to create 3D monochromatic images. Advanced technologies like AI-based solutions, Computer-aided detection, and Fusion imaging enhance the diagnostic accuracy of these systems. Diagnostics imaging laboratories and Radiologists increasingly rely on ABUS to detect Mammographically Occult Cancer and improve the diagnostic procedural volume. However, the rising trend of elective surgeries and non-essential screenings due to factors like Alcohol consumption, Smoking, Obesity, and Sedentary Lifestyle has led to an increased Breast Cancer Incidence. ABUS plays a crucial role in Early Detection of Breast Lesions, making it an indispensable tool in the fight against Breast Cancer. With advancements in technology, wearable ultrasound devices and Digital Cancer Screening are also gaining popularity. However, the interpretation of ABUS images requires Skilled Radiologists to ensure accurate diagnosis. In conclusion, Automated Breast Ultrasound Systems offer significant benefits in Cancer Detection and are an essential component of comprehensive Breast Cancer Screening programs. With continued advancements in technology and imaging techniques, ABUS is set to revolutionize the field of diagnostics and contribute to improved patient outcomes.
In the broader context of the global healthcare equipment market, Automated Breast Ultrasound Systems (ABUS) represent a significant segment. This market, as identified by Technavio, encompasses manufacturers and innovators specializing in the research, development, and production of capital equipment, instruments, implants, accessories, and consumables. These solutions are integral to the diagnosis, monitoring, and treatment of various diseases. The size of the global healthcare equipment market is determined by Technavio through the consolidated revenue generated by manufacturers of diagnostic equipment and devices, including advanced, differentiated, and clinically validated devices such as ABUS. The healthcare equipment industry is segmented into Devices, which includes the aforementioned advanced and clinically tested devices.
The Automated Breast Ultrasound Systems (ABUS) Market is experiencing significant growth, fueled by the increasing demand for breast imaging products owing to the growing prevalence of breast cancer cases. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
Safe and Secure SSL Encrypted
One user only.
Quick & easy download option
Unlimited user access (Within your organization).
Complimentary Customization Included
*For Enterprise license, go to checkout page
Get the report (PDF) sent to your email within minutes.
